The Original Investigation titled, “Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial,”1 published online April 22, 2021, included a missing group name in the subtitle, incorrect dates of data analysis in the abstract and Methods, and an incorrect population icon in the Visual Abstract. This article has been corrected online.
Reference
- 1.Falandry C, Rousseau F, Mouret-Reynier MA, et al. ; Groupe d’Investigateurs Nationaux pour l’Étude des Cancers de l’Ovaire et du sein (GINECO) . Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian cancer: a GINECO/GCIG randomized clinical trial. JAMA Oncol. Published online April 22, 2021. doi: 10.1001/jamaoncol.2021.0696 [DOI] [PMC free article] [PubMed] [Google Scholar]